يعرض 1 - 20 نتائج من 39,449 نتيجة بحث عن 'significantly ((related decrease) OR (reported case))', وقت الاستعلام: 0.41s تنقيح النتائج
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7

    Motifs significantly enriched in decreased ATAC peaks relative to unchanged ATAC peaks at 30 minutes. حسب Thomas G. Scott (4092892)

    منشور في 2024
    "…<p>Motifs significantly enriched in decreased ATAC peaks relative to unchanged ATAC peaks at 30 minutes.…"
  8. 8
  9. 9
  10. 10
  11. 11

    Henoch-Schönlein purpura nephritis associated with monoclonal gammopathy of renal significance: a case report حسب Hui Zhao (7395)

    منشور في 2019
    "…The Henoch-Schönlein purpura nephritis (HSPN) that cannot be relieved by treatment with glucocorticoid and immunosuppressive agents suggests the presence of monoclonal gammopathy in adult patients. The present study reports on a single case of HSPN associated with IgA-κMGRS. …"
  12. 12
  13. 13
  14. 14

    Data Sheet 1_Case report: Achieving significant tumor reduction in advanced pancreatic adenocarcinoma.docx حسب Hongying Liu (773217)

    منشور في 2024
    "…However, certain genetic profiles, such as BRCA1/2 mutations, high tumor mutational burden (TMB), or microsatellite instability-high (MSI-H), may enhance sensitivity to these therapies. This report presents two cases of advanced pancreatic cancer with BRCA1/2 mutations treated with a combination of chemotherapy and immune checkpoint inhibitors. …"
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19

    Data Sheet 1_Case Report: Efgartigimod demonstrates significant clinical efficacy in double seropositive myasthenia gravis: a case report of a rare variant and analysis of pathomechanisms.pdf حسب Xiaohui Huang (458909)

    منشور في 2025
    "…Currently, no standardized therapeutic protocol exists for DSP-MG due to its scarcity and clinical heterogeneity. Herein, we report a case of a 68-year-old female patient with DSP-MG who showed significant clinical improvement during an acute exacerbation after treatment with the FcRn antagonist efgartigimod, following the failure of conventional therapy. …"
  20. 20